Source comparison
CJC-1295 no DAC & Ipamorelin vs Sermorelin: Research Application Comparison
The following table directly compares the kinetic, mechanistic, and application characteristics that determine which peptide suits specific research protocols. Mechanism of Action Dual-pathway: GHRH receptor (CJC-1295) + ghrelin receptor (Ipamorelin) producing
This comparison does not assign a generated winner or score.
- The following table directly compares the kinetic, mechanistic, and application characteristics that determine which peptide suits specific research protocols.
- Mechanism of Action
- Dual-pathway: GHRH receptor (CJC-1295) + ghrelin receptor (Ipamorelin) producing synergistic GH release
- GHRH receptor agonism—mimics endogenous growth hormone-releasing hormone with 29-amino-acid active sequence
- CJC/Ipamorelin delivers greater total GH AUC; Sermorelin replicates physiological pulsatility more precisely
- Half-Life
- CJC-1295: ~30 min; Ipamorelin: ~2 hours; combined kinetic profile sustains GH elevation 8–12 hours
- 10–20 minutes plasma half-life; GH pulse returns to baseline within 60–90 minutes
- Sustained vs pulsatile—the single most important protocol design factor
- Dosing Frequency
- Once or twice daily depending on study design; twice-daily produces overlapping kinetic curves
- Once daily, typically evening administration to align with nocturnal GH surge
- CJC/Ipamorelin suits protocols requiring stable daily GH exposure; Sermorelin suits circadian studies
- IGF-1 Response
- Sustained GH elevation produces 4–6× greater IGF-1 AUC vs Sermorelin at equivalent molar GH output
- Sharp GH pulse produces smaller, delayed IGF-1 elevation due to short hepatic exposure window
- Anabolic endpoints requiring IGF-1 signaling favor CJC/Ipamorelin; acute GH studies favor Sermorelin
- Ideal Research Applications
- Metabolic studies, body composition protocols, sustained lipolysis measurement, IGF-1 kinetics, anabolic signaling pathways
- Circadian rhythm studies, sleep-related GH research, pulsatile vs continuous GH comparison models, acute metabolic response
- Match peptide kinetics to research question—duration and pulsatility determine data validity
- Receptor Selectivity
- Highly selective—minimal cortisol, prolactin, ACTH elevation; dual pathways prevent single-receptor desensitization
- Highly selective for GH release; no significant secondary endocrine activation at standard doses
- Both maintain clean GH elevation without confounding hormonal variables
- This comparison clarifies the primary decision point: research teams measuring cumulative effects over hours or days should select CJC-1295 no DAC & Ipamorelin; teams studying discrete pulsatile events or circadian GH dynamics should select Sermorelin. The peptides aren't interchangeable—they answer fundamentally different research questions.